SUBSCRIBE NOW

SIGHT

Be informed. Be challenged. Be inspired.

Indian data suggests runaway COVID infections as deaths hit daily record

Bengalaru, India
Reuters

Nearly two-thirds of people tested in India have shown exposure to COVID-19, a chain of private laboratories said on Wednesday, indicating a runaway spread of the virus as the daily death toll rose to a record 4,529.

India reported 267,334 new daily infections on Wednesday, taking its tally to 25.5 million, the world’s second highest after the United States, with a death toll of 283,248, health ministry data showed.

Coronavirus India Uttar Pradesh Mewla Gopalgarh

Harveer Singh, 65, a villager suffering from COVID-19 rests in a cot as he receives treatment at a makeshift open-air clinic, amidst the spread of the coronavirus disease (COVID-19), in Mewla Gopalgarh village, in Jewar district, in the northern state of Uttar Pradesh, India, on 16th May. PICTYURE: Reuters/Danish Siddiqui.

For months, nowhere has been hit harder than India by the pandemic, as a new variant discovered there fuelled a surge of up to more than 400,000 new infections a day.

Only the United States has had a worse single day death toll, when it lost 5,444 people on 12th February a Reuters tracker shows.

And with hospitals and crematoria overflowing and the health system overwhelmed, it is widely accepted that the official figures grossly underestimate the real impact of the epidemic, with some experts saying infections and deaths could be five to 10 times higher.

There are fears that the new, highly infectious variant is out of control and that many cases are going unreported because of lack of testing, particularly in the vast countryside.

Data from Thyrocare, a chain of private laboratories, appeared to back up those fears, showing that 63.5 per cent of people tested positive for COVID-19 antibodies on average over the last seven days, up from 45 per cent a month ago.

The data from 25 states included individuals infected in the past, vaccinated, uninfected and those who had not been vaccinated, the company’s Chief Executive Arokiaswamy Velumani said on Twitter.

Criticism of Prime Minster Narendra Modi has been rising but M Govinda Rao, a former member of the Economic Advisory Council to the Prime Minister, said the rate at which the virus was spreading had caught everyone by surprise.

“The unprecedented speed at which the second wave of the pandemic spread completely took the [state] governments as well as the people off guard,” Rao told the Hindu newspaper.

Few tests in the hinterland
Daily testing hit a record two million on Tuesday, figures from the state-run Indian Council of Medical Research showed. 

But that still falls short of India’s claimed daily testing capacity of 3.3 million, said Rijo M John, a professor at the Rajagiri College of Social Sciences in the southern city of Kochi.

John also questioned how useful the results of the tests were.

“Many of these tests are being deployed in urban centres, where cases may have peaked and so it doesn’t serve much purpose,” John said.

“It’s time they were diverted to more rural areas, but I doubt that is being done.” 

Modi’s approval has fallen to a new low, two surveys showed.

Polling agency CVOTER found that for the first time in the seven years Modi has been in office there were more people expressing dissatisfaction with his government’s performance than satisfaction.

Hospitals have had to turn patients away while mortuaries and crematoria have been unable to cope with bodies piling up.

Photographs and television images of funeral pyres burning in parking lots and corpses washing up on the banks of the Ganges river have fuelled impatience with the government.

India is the world’s largest vaccine maker, but criticism has also mounted over its slow vaccination campaign, plagued by a lack of supplies.

The government said about 98 per cent of the population of 1.3 billion remained susceptible to infection.

India halted vaccine exports a month ago after donating or selling more than 66 million doses, and government sources told Reuters it was unlikely to resume major exports of vaccines until at least October as it prioritises domestic needs.

– With reporting by RAMA VENKAT in Bengaluru.

 

Donate



sight plus logo

Sight+ is a new benefits program we’ve launched to reward people who have supported us with annual donations of $26 or more. To find out more about Sight+ and how you can support the work of Sight, head to our Sight+ page.

Musings

TAKE PART IN THE SIGHT READER SURVEY!

We’re interested to find out more about you, our readers, as we improve and expand our coverage and so we’re asking all of our readers to take this survey (it’ll only take a couple of minutes).

To take part in the survey, simply follow this link…

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.